Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1.

The Journal of experimental medicine | 2003

The cyclooxygenase-2 (COX-2) enzyme catalyzes the rate-limiting step of prostaglandin formation in inflammatory states, and COX-2 overexpression plays a key role in carcinogenesis. To understand the mechanisms regulating COX-2 expression, we examined its posttranscriptional regulation mediated through the AU-rich element (ARE) within the COX-2 mRNA 3'-untranslated region (3'UTR). RNA binding studies, performed to identify ARE-binding regulatory factors, demonstrated binding of the translational repressor protein TIA-1 to COX-2 mRNA. The significance of TIA-1-mediated regulation of COX-2 expression was observed in TIA-1 null fibroblasts that produced significantly more COX-2 protein than wild-type fibroblasts. However, TIA-1 deficiency did not alter COX-2 transcription or mRNA turnover. Colon cancer cells demonstrated to overexpress COX-2 through increased polysome association with COX-2 mRNA also showed defective TIA-1 binding both in vitro and in vivo. These findings implicate that TIA-1 functions as a translational silencer of COX-2 expression and support the hypothesis that dysregulated RNA-binding of TIA-1 promotes COX-2 expression in neoplasia.

Pubmed ID: 12885872 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R01 AI50167
  • Agency: NIAID NIH HHS, United States
    Id: R56 AI033600
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI033600
  • Agency: NCI NIH HHS, United States
    Id: P30 CA68485
  • Agency: NCI NIH HHS, United States
    Id: P01 CA73992
  • Agency: NCI NIH HHS, United States
    Id: CA42014
  • Agency: NIAID NIH HHS, United States
    Id: AI33600
  • Agency: NCI NIH HHS, United States
    Id: P01 CA77839
  • Agency: NCI NIH HHS, United States
    Id: P01 CA077839
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI050167
  • Agency: NCI NIH HHS, United States
    Id: P30 CA068485
  • Agency: NIDDK NIH HHS, United States
    Id: DK-52334
  • Agency: NCI NIH HHS, United States
    Id: P01 CA073992
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK052334
  • Agency: NCI NIH HHS, United States
    Id: P30 CA042014

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


LoVo (tool)

RRID:CVCL_0399

Cell line LoVo is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HeLa (tool)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions